Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER
Research Comparison

KPV vs TB-500 (Thymosin Beta-4)

KPV and TB-500 (Thymosin Beta-4) are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.

Shared research areas:Tissue Regeneration
ClassTripeptide (Lys-Pro-Val), alpha-MSH C-terminal fragmentSynthetic fragment of Thymosin Beta-4
Molecular weight342.4 g/mol4963.5 g/mol
CAS numberNot assigned / not specified77591-33-4
Purity spec≥99%≥99%
Research areasGastrointestinal, Tissue RegenerationTissue Regeneration, Musculoskeletal, Cardiovascular
Primary diluentBacteriostatic water (0.9% benzyl alcohol)Bacteriostatic water (0.9% benzyl alcohol)
Working windowCommonly worked with for 3-4 weeks at 2-8 °C.Commonly worked with for 2–4 weeks at 2–8 °C.
Lead degradation routeAdsorptive loss to plasticware at very low working concentrations — the main practical concern for such a small molecule.Methionine sulfoxide formation — the dominant chemical degradation route, detectable as an earlier-eluting shoulder on RP-HPLC and a +16 Da species on LC-MS.
Freeze–thawVery tolerant; a tripeptide has no structure to disrupt. Aliquot to limit repeated handling.Aliquot after reconstitution. Repeated cycles risk both concentration effects and progressive oxidation from headspace air introduced at each opening.
Light sensitivityNo specific light requirement beyond normal practice.Store reconstituted vials protected from light; methionine oxidation is accelerated by light and dissolved oxygen.

How they actually differ

Comparing the two: KPV is tripeptide (lys-pro-val), alpha-msh c-terminal fragment, while TB-500 (Thymosin Beta-4) is synthetic fragment of thymosin beta-4 — different molecular classes with different handling consequences; their leading degradation routes differ (adsorptive loss to plasticware at very low working concentrations for KPV, methionine sulfoxide formation for TB-500 (Thymosin Beta-4)), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.

KPV — origin

KPV is the three-residue C-terminal tail of alpha-melanocyte-stimulating hormone. It retains the anti-inflammatory character associated with the parent hormone while lacking the melanocortin-receptor region responsible for pigmentation — the reason it is studied for inflammation without a tanning effect.

TB-500 (Thymosin Beta-4) — origin

TB-500 corresponds to the active region of Thymosin Beta-4, a 43-residue actin-sequestering protein present in virtually every mammalian cell type and abundant in wound fluid and platelets. Research interest followed the observation that the protein's activity in tissue-organisation models is largely retained by a short fragment of it.

KPV research themes

Anti-inflammatory signalling

Studied for modulation of inflammatory pathways such as NF-kB in cell and tissue models, inherited from the alpha-MSH parent.

Gastrointestinal models

A significant share of the literature examines gut-inflammation research models.

Skin and tissue

Investigated in dermal and tissue-repair contexts without the pigmentation activity of the full hormone.

TB-500 (Thymosin Beta-4) research themes

Actin sequestration

The defining studied mechanism: binding G-actin and influencing the polymerisation equilibrium that governs cell motility.

Cell migration models

Investigated in models where directed cell movement into a tissue defect is the measured endpoint.

Cardiac and corneal repair models

Two of the better-populated preclinical literatures for the parent protein.

Inflammation modulation

Studied for effects on inflammatory signalling in tissue-injury models.

KPV handling

  • Reach room temperature before opening.
  • Use low-bind labware at very low working concentrations to limit adsorption.
  • Label aliquots with reconstitution date and diluent.

TB-500 (Thymosin Beta-4) handling

  • Minimise headspace exposure — each opening introduces oxygen that drives methionine oxidation.
  • Keep reconstituted vials out of direct light, including bench lighting over long sessions.
  • Introduce diluent against the vial wall; the cake is light and can be dispersed by a direct stream before it dissolves.

Both third-party tested

Every Popular Peptides batch of KPV and TB-500 (Thymosin Beta-4) is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

Verify a batchPublished COAsHow we test

KPV reference

Full KPV reference KPV storage KPV reconstitution KPV calculatorKPV product details

TB-500 (Thymosin Beta-4) reference

Full TB-500 (Thymosin Beta-4) reference TB-500 (Thymosin Beta-4) storage TB-500 (Thymosin Beta-4) reconstitution TB-500 (Thymosin Beta-4) calculatorTB-500 (Thymosin Beta-4) product details

Related comparisons

ARA 290 vs KPVARA 290 vs TB-500 (Thymosin Beta-4)BPC-157 vs KPVBPC-157 vs TB-500 (Thymosin Beta-4)GHK-Cu vs KPVGHK-Cu vs TB-500 (Thymosin Beta-4)GLOW vs TB-500 (Thymosin Beta-4)IGF-1 LR3 vs TB-500 (Thymosin Beta-4)

KPV and TB-500 (Thymosin Beta-4) are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.